Research Topics
| Steven B ZeliadtSummaryAffiliation: Fred Hutchinson Cancer Research Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancerSteven B Zeliadt
Fred Hutchinson Cancer Research Center, Health Services Department, University of Washington School of Public Health and Community Medicine, Seattle, WA 98109 1024, USA
Int J Radiat Oncol Biol Phys 66:395-402. 2006..This study examines the effectiveness of adjuvant ADT combined with radiotherapy for a wide range of patients treated in the 1990s...- Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999Steven B Zeliadt
Department of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
Urology 64:1171-6. 2004..To assess trends in the initial care of nonmetastatic prostate cancer, including the use of primary and adjuvant androgen deprivation therapy (ADT), using population-based treatment claims from 1991 to 1999... - Trends in treatment costs for localized prostate cancer: the healthy screenee effectSteven B Zeliadt
Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
Med Care 45:154-9. 2007..We sought to obtain estimates of trends in initial treatment costs during the prostate-specific antigen (PSA) era that account for the changing patient case-mix associated with screening... 
Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancerScott D Ramsey
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
Urology 79:1034-41. 2012..To evaluate the association between complementary and alternative medicine (CAM) use, satisfaction with treatment, and patient-reported outcomes after treatment...
Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinionsScott D Ramsey
Fred Hutchinson Cancer Research Center, 1100 Fairview Ave North, M3 B232, Seattle, WA 98109 1024, USA
World J Urol 29:3-9. 2011..We hypothesized that urologists present a wider range of management recommendations and are less likely to consider the patient preference during the initial consultation...- Discontinuation of radiation treatment among medicaid-enrolled women with local and regional stage breast cancerScott D Ramsey
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
Breast J 16:20-7. 2010..More effort is needed to ensure this vulnerable population receives adequate radiation following BCS... - Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancerSteven B Zeliadt
Department of Veterans Affairs Medical Center, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
BJU Int 108:851-6; discussion 856-7. 2011..To evaluate the degree to which the partners of prostate cancer patients participate in the shared decision-making process with the patients' providers during the time between diagnosis and initiating treatment... - Complementary and alternative medicine use among newly diagnosed prostate cancer patientsCara L McDermott
Fred Hutchinson Cancer Research Center, 1100 Fairview Ave North, M3 B232, Seattle, WA 98109 1024, USA
Support Care Cancer 20:65-73. 2012..We surveyed prostate cancer patients about complementary and alternative medicine (CAM) use and evaluated patient factors that correlated with CAM use 6 months following diagnosis... - Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective surveyScott D Ramsey
Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
J Urol 184:120-5. 2010.... - Patient recruitment methods to evaluate treatment decision making for localized prostate cancerSteven B Zeliadt
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Am J Clin Oncol 33:381-6. 2010..To examine methods for identifying and recruiting prostate cancer patients prior to initiating treatment to gain insight into the treatment decision process and avoid recall bias... - Preliminary treatment considerations among men with newly diagnosed prostate cancerSteven B Zeliadt
Health Services Research and Development Center of Excellence, VA Puget Sound Health Care System, Seattle, WA, USA
Am J Manag Care 16:e121-30. 2010..To assess factors that may influence men's preference for surgery versus nonsurgical options among newly diagnosed patients considering treatments for local-stage prostate cancer... - On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancerScott D Ramsey
Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA
J Urol 177:1992-9. 2007..To determine the completeness and quality of available health related quality of life information we performed a review of health related quality of life studies, assessing what information was and was not reported... - Influence of publication of US and European prostate cancer screening trials on PSA testing practicesSteven B Zeliadt
Health Services Research and Development Center of Excellence, VA Puget Sound Health Care System, Seattle, WA 98101, USA
J Natl Cancer Inst 103:520-3. 2011..PSA testing among men older than 75 years initially declined slightly following the recommendations by the US Preventive Services Task Force in 2008 and continued to decline after the trial publications... - An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United StatesPamela A Shaw
Fred Hutchinson Cancer Research Center, Seattle, WA, 98109-1024, USA
Am J Epidemiol 160:1059-69. 2004..Ecologic analyses of the effectiveness of PSA testing should be interpreted with caution... - Access to information sources and treatment considerations among men with local stage prostate cancerScott D Ramsey
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
Urology 74:509-15. 2009..Diagnosed men have access to a large number of information sources about therapy, including print and broadcast media, the Internet, books, and friends with the disease... - Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosisSteven B Zeliadt
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA
Cancer 98:496-503. 2003..Further research is needed to identify the reasons for the racial disparity in PSA surveillance and to design interventions to lessen these differences... - Biopsy follow-up of prostate-specific antigen testsSteven B Zeliadt
Health Services Research and Development Service, Department of Veterans Affairs Medical Center, Seattle, Washington 98101, USA
Am J Prev Med 42:37-43. 2012.... - Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancerSteven B Zeliadt
Fred Hutchinson Cancer Research Center, Seattle, Wash 98109, USA
Am J Med 118:850-7. 2005.... - Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancerSteven B Zeliadt
Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington 98109, USA
Cancer 106:1865-74. 2006..Considerable progress is needed in helping patients fully understand how to balance the complex issues surrounding prostate cancer treatment decision making... - What happens after an elevated PSA test: the experience of 13,591 veteransSteven B Zeliadt
VA Health Services Research and Development Service, Department of Veterans Affairs Medical Center, Seattle, WA 98101, USA
J Gen Intern Med 25:1205-10. 2010..The occurrence and timing of prostate biopsy following an elevated prostate-specific antigen (PSA) test varied considerably in randomized screening trials... - Prostate cancer mortality following active surveillance versus immediate radical prostatectomyJing Xia
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, WA, USA
Clin Cancer Res 18:5471-8. 2012..The purpose of this study is to project prostate cancer mortality under active surveillance followed by radical prostatectomy versus under immediate radical prostatectomy... - Pharmacoeconomics of available treatment options for metastatic prostate cancerSteven B Zeliadt
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Pharmacoeconomics 25:309-27. 2007..It is essential that we address the weaknesses in our understanding of the economic consequences of therapies for prostate cancer, and find ways to include economic information into the process of determining optimal therapy... - Cost-effectiveness of prostate cancer chemoprevention among high-risk menSteven B Zeliadt
VA Health Services Research and Development Service, Department of Veterans Affairs Medical Center, Seattle, WA 98101, USA
Expert Rev Pharmacoecon Outcomes Res 10:505-8. 2010.... - Disenrollment from Medicaid after recent cancer diagnosisScott D Ramsey
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
Med Care 46:49-57. 2008..We examine the frequency with which newly diagnosed cancer patients are covered by Medicaid in Washington State and the duration of coverage... - Estimated impact of the prostate cancer prevention trial on population mortalitySteven B Zeliadt
Cancer 104:1556-7; author reply 1557. 2005 - Localized prostate cancer: quality of life meets Whitmore's legacyCarlos Bermejo
J Natl Cancer Inst 96:1348-9. 2004
Research Grants
- Reassessing the Quality of Life Burden of Prostate Cancer SurvivorshipSTEVEN ZELIADT; Fiscal Year: 2007..The results of this study will aid patients, physicians, and policy makers in decisions related to prostate cancer management. ..